Fkiv-aceinh,angioantag2006

  • June 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Fkiv-aceinh,angioantag2006 as PDF for free.

More details

  • Words: 1,266
  • Pages: 21
Zaviralci angiotenzinske konvertaze (ACE) Antagonisti receptorjev angiotenzina II D. Kikelj

Sistem renin - angiotenzin angiotenzinogen Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu- Val-Ile-His-Protein

ditekeren, enalkiren remikiren, zankiren

renin angiotenzin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe- His-Leu angiotenzin konvertaza (ACE) angiotenzin I kimaza angiotenzin II Asp -Arg-Val-Tyr-Ile-His-Pro-Phe

Stimulira izlo anje aldosterona !!!

aminopeptidaze neaktivni peptidni fragmenti

angiotenzin III Arg-Val-Tyr-Ile-His-Pro-Phe angiotenzinaze

1

Angiotenzin konvertaza angiotenzin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu angiotenzin konvertaza (ACE)

angiotenzin II Asp-Arg-Val-Tyr-Ile-His-Pro-Phe

Bothrops jararaca

Ferreira, 1965

2

Spojina Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro

Ki/ IC50 teproid

Ki = 100 nM

CH3 H2N

N O

Ki = 230 µM

COOH

N

HOOC O

IC50 = 70 µM

COOH

CH3 N

HOOC O

IC50 = 4.9 µM

COOH

CH3 HS

N O

kaptopril COOH

ACE - membranski glikoprotein

IC50 = 23 nM Ki = 1.7 nM

M = 1.3-1.6 kDa

sekvenca dolo ena 1988

Ondetti, Cushman: hipoteza, da je ACE strukturno podobna karboksipeptidazi A (metaloproteaza), za katero je bila znana kristalna struktura (Lipscomb) in inhibitor (benziljantarjeva kislina)

3

Struktura kompleksa karboksipeptidaza A - benziljantarjeva kislina

Karboksipeptidaza A v

v

lipofilni zep

lipofilni zep

Zn2+

Zn2+

O

H N R

O N H

O +

NH2

O H2N

substrat

N H

O

HO O

H2N

+

NH2

N H

inhibitor (benziljantarjeva kislina)

Lipscomb

4

Inhibitorji ACE O R

R

2

N H

3

O

R

O

R

O

H N

2

1

O

substrat

OH

inhibitor

O

H N

HO

OH

R

1

Razvoj kaproprila (1980) Spojina Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro

Ki/ IC50 teproid

Ki = 100 nM

CH3 H2N

N O

Ki = 230 µM

COOH

N

HOOC O

IC50 = 70 µM

COOH

CH3 N

HOOC O

IC50 = 4.9 µM

COOH

CH3 HS

N O

kaptopril COOH

IC50 = 23 nM Ki = 1.7 nM

Ondetti (Squibb)

5

Enalapril - predzdravilo (1984) biotransformacija

CH3 EtOOC

N H

CH3

N

HOOC

O

N H

COOH

IC50 = 1 nm Ki = 0.2 nM

enalapril

N

O

COOH

enalaprilat

N O CH3 EtOOC

N H

O N

H3C

N

O

COOEt

COOEt

Registrirani inhibitorji ACE NH2 CH3

HS

CH3

N

O

COOH

kaptopril (1980, Bristol-Myers Squibb)

ROOC

N H

O

H3C

N COOH

R = C2H5: enalapril (Merck, 1984) R = H: enalaprilat (Merck, 1987)

S CH3 EtOOC

N H

CH3 EtOOC

N

O

COOH

delapril (Takeda, 1989)

N H

O

HOOC

N H

COOH

spirapril (Novartis, 1995)

H3C

N

O

COOH

lizinopril (1987, Merck)

N H

O

CH3 EtOOC

N H

N

O

EtOOC COOH

n = 1: ramipril (HMR, 1989) n = 2: trandolapril (HMR, 1993)

N H

COOH

N H

EtOOC

COOH

cilazapril (Roche, 1990)

EtCOO H3C

O P O CH 3

N O

EtOOC COOH

fosinopril (Bristol-Myers Squibb, 1991)

imidapril (Tanabe, 1993)

EtOOC

N H

N O

COOH

temokapril (Sankyo, 1994)

CH3 EtOOC

O

COOH

benazepril (Novartis, 1990)

S

S

COOH

N

N H

R CH3 O N CH3 N N H O COOH

N

O

perindopril (Daiichi, 1988)

N N O

CH3

EtOOC

alacepril (1988, Dainippon)

n

S

N

CH3

O

N O

S

N H

O

R

N COOH

R = H: quinapril (Parke-Davis, 1989) R = OMe: moexipril (Warner-Lambert, 1995)

6

Tipi inhibitorjev ACE NH2 HS

CH3

CH3

N ROOC

COOH

O

kaptopril

N

N H

COOH

O

HOOC

N

N H

enalapril

lizinopril

CH3 EtCOO H3C

O

N

P

O CH3

ROOC

CH3 N

N H

COOH

O

COOH

O

ROOC COOH

O

N

N H

O

COOH

fosinopril

CH3 ROOC

N H

N

O

COOH

enalapril H3C

n CH3

EtOOC

N H

CH3

N

EtOOC

O

COOH

R

CH3 N H

CH3

N

O

O CH3 N H

O

imidapril

O

EtOOC COOH

N N

N H

O

COOH

cilazapril

R

EtOOC COOH

R = H: quinapril R = OMe: moexipril

EtOOC

N

n = 1: ramipril n = 2: trandolapril

perindopril

EtOOC

N H

N H

EtOOC

N

O

COOH

S

CH3 N

CH3 EtOOC

COOH

N

N H

COOH

O

benazepril

delapril

N

N H

O

spirapril

S

S N COOH

S EtOOC

N H

N O

COOH

temokapril

7

Kombinatorna kemija... CH3 HS

N O

COOH

kaptopril (Ki = 1.7 nm)

COOCH3 HS

CH3 O

N COOH

Affymax

(Ki = 160 pm)

Sinteza kaptoprila

8

Sinteza enalaprilata in enalaprila

PhCH2CH2MgBr

(COOEt)2

EDC/HOBt metoda tvorbe peptidne vezi

9

Sinteza lizinoprila

Sinteza perindoprila Me(CH2)2COCOOEt

L-Ala

10

Sinteza perindoprila 1. Redukcija 2. H3C

O COOEt

Fischerjeva sinteza indolov

Dobljen z reduktivnim aminiranjem

Sinteza fozinoprila

11

Sinteza fozinoprila

Sinteza fozinoprila

12

Sinteza fozinoprila

tioketal

Reduktivno aminiranje

aktivni ester N-hidroksisukcinimida

Sinteza spiraprila

13

Sinteza omapatrilata Inhibitor neutralne endopeptidaze,

Dualni inhibitor ACE in neutralne endopeptidaze Swernova oksidacija

ki razgrajuje ANP s hipotenzivnimi lastnostmi

14

!

Natesh R et al. Nature 2003, 551

Zaviralci angiotenzinske konvertaze (ACE) Antagonisti receptorjev angiotenzina II D. Kikelj

15

Sistem renin - angiotenzin angiotenzinogen Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu- Val-Ile-His-Protein renin

antagonisti

angiotenzin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe- His-Leu angiotenzin konvertaza (ACE) angiotenzin I kimaza

vezava na AT receptorje

angiotenzin II Asp -Arg-Val-Tyr-Ile-His-Pro-Phe aminopeptidaze

neaktivni peptidni fragmenti

angiotenzin III Arg-Val-Tyr-Ile-His-Pro-Phe angiotenzinaze

Razvoj losartana Cl

saralazin Sar-Arg-Val-Tyr-Val-His-Pro-Ala

N

COO

Takeda, S-8308

-

N

spojina vodnica

kisle skupine

1982

NO2

+

H2N

NH2

HO

H N

HN O H2N -

OOC

N H

H N O

O N H

H N O

N

O N H

N O

O

N H

COO

-

angiotenzin

16

Razvoj losartana Cl

Cl

Cl

N

COO

N

N

-

N

COO

-

COOEt N

N

O NO2

N H

COOH

HOOC

S-8308 IC50 = 15 µ M

IC50 = 1.2 µ M

IC50 = 0.12 µM

Cl N

Cl N

OH N

OH N

N

N HOOC

N NH IC50 = 0.019 µ M

IC50 = 0.23 µ M

losartan

peroralno uporabna!

Antagonisti angiotenzina II Cl HO

CH3

H3C

N

HO

N N - + NK N

N

O

CH3 O

CH3

CH3

CH3

S

N

N

N N NH N

N

HOOC

O

N N N NH

N

N

COOH

losartan (Merck, Banyu, 1994)

valsartan (Novartis, 1996)

eprosartan (SmithKline Beecham, 1997)

CH3 O O

O

O

CH3

N

CH3

N O

O

N N NH N

candesartan cileksetil (Takeda, 1997)

N N CH3

Cl N

CH3 HOOC

N

CH3 N N

O N N NH N

O

CH3 H3C

O

O O

COOH

telmisartan (Boehringer Ingelheim, 1999)

irbesartan (Bristol-Myers Squibb, 1997)

EXP-3174 (faza III)

CH3

OH N

N

CH3 N N N NH

CS-866 (Sankyo, faza III)

17

Sinteza losartana

Sinteza losartana

18

Sinteza losartana

BrCH2 BrCH2

N N N N N N N N Tr Tr

N N H3C

N

N

Tr

Ullmannova reakcija

Sinteza losartana

19

Swernova oksidacija

Sinteza valsartana

reduktivno aminiranje

Sinteza valsartana

20

Sinteza irbesartana O

H2N

1. NaCN 2. NH3

H3C

1. H2SO4 2. C4H9-COCl

CN

H N N

O

Br

, NaH O

N

O

N

NaN3

H3C

N

CN

N

N H3C

N N

NC

N H

irbesartan

Sinteza kandesartana COOH

COOMe

1. MeO H, H+ 2 . S O C l2

COOH

C O Cl

N H C O O -t- B u

Schmittova reakcija

NO2

NO2

COOMe

1. NaN3 2 . t-B u O H

NO2 Br

, NaH 1 . S n C l2 2 . e tilo r to k a rb o n a t

COOMe CN

N H

NC

NO2 1. N aN 3 2 . N a O H , H 2O 3. T rC l

COOMe N

N

NC

O Et

N

COOH

N

O Et

N N

N

N O

O

O O

O C H3

O O

O N N

O Et

Tr I Me

, N aO H

N N

N

N

Tr

k a n d e s a r ta n c ile k s e til

21